Effect of Glucagon‐Like Peptide‐1 Receptor Agonists on Renal and Cardiovascular Risk Factors in Patients With Type 2 Diabetes Mellitus: A Retrospective Study
This study affirms the effectiveness of GLP-1RAs as a glycemic control agent with an additional benefit of weight reduction across a 12-month period in adult T2DM patients. No effect on other cardiovascular parameters apart from weight or renal risk factors was observed. Further investigation into the influence of GLP-1RAs on these would be beneficial.
Authors
- Daniel Yuan (ORCID: https://orcid.org/0000-0002-9426-6146)
- Usman H. Malabu (ORCID: https://orcid.org/0000-0003-4899-7228)
- Oluwatosin Adetola Arojojoye (ORCID: https://orcid.org/0000-0002-2300-0658)
- Venkat Vangaveti (ORCID: https://orcid.org/0000-0002-4363-309X)
Institutions
- Townsville Hospital (AU)
- James Cook University (AU)
Publication Details
- Journal
- Journal of Diabetes Research
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1155/jdr/2663671
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00